Welcome to OpenDEL™ Community

A central hub to connect with global DEL professionals, access the latest industry insights and product updates, and collaborate to accelerate drug discovery.

DEL Hunter

  • DEL-Related Publications

    DNA-scaffolded catalysis for aliphatic alcohol oxidation in DEL synthesis

    Ethan M. Hartman, Jeffrey D. Martell Chemical Science DOI: 10.1039/d6sc05041g Abstract          Compared to traditional methods for screening small molecule drug candidates, DNA-encoded libraries (DELs) offer greatly increased throughput by tethering each small molecule to unique DNA barcodes, allowing simultaneous screening of billions of small molecules in a single test-tube. Impressive advances have been made in adapting traditional organic reactions to be DNA-compatible, allowing for the synthesis of DELs with ever-expanding chemical diversity. Nonetheless, DNA is a fragile molecule that is damaged by many chemical reaction conditions, making these conditions incompatible with DEL synthesis. The fragility of DNA therefore necessitates the development of new platforms to accelerate the desired transformation of the tethered small molecules while minimizing damage to the DNA barcodes. Here, we report a DNA-scaffolded catalysis platform for high-yielding, high-selectivity transformations in the construction of DELs under mild conditions. Through DNA-scaffolding, the catalyst is brought in proximity to DNA-tethered small molecules, lowering the catalyst concentration needed and minimizing off-target DNA damage. We demonstrate the platform in the context of aliphatic alcohol oxidation, a transformation for which conventional reactions with free-floating catalysts cause oxidative DNA damage. We further demonstrate that the DNA-scaffolded DEL synthesis platform can be incorporated into existing DEL synthesis workflows. We anticipate that the DNA-scaffolded DEL synthesis platform will find broad utility in improving the DNA-compatibility of organic transformations and will expand the toolkit of DNA-compatible chemical reactions.

  • DEL-Related Publications

    On-DNA photochemical methods for expanding DNA-encoded library (DEL) chemical space

    Oliver J. Corrigan, Sarah L. Allinson, Jamie H. Docherty RSC Medicinal Chemistry DOI:10.1039/d6md00764c Abstract                    DNA-encoded libraries (DELs) have become a mainstay of small-molecule discovery, enabling millions to billions of compounds to be screened in a single pooled affinity selection in which each small molecule is covalently linked to a unique DNA identifier. However, the chemistry available for their construction remains limited compared to conventional synthetic chemistry. On-DNA chemistry is constrained by the requirement for aqueous, dilute, and DNA-compatible conditions. Classical on-DNA reactions such as amide coupling, reductive amination, SNAr and transition-metal cross-coupling have enabled reliable library synthesis, but they tend to favour planar, sp2-rich products. Photochemistry and photocatalysis have recently emerged as a powerful strategy to broaden this toolbox. Excited-state activation opens reaction pathways that are difficult or impossible to reach through conventional ground-state chemistry and can facilitate novel transformations towards the construction of more complex and sp3-rich scaffolds. This review surveys the field of on-DNA photochemistry, looking at different activation modes including photoredox single-electron transfer (SET), hydrogen-atom transfer (HAT), metallaphotoredox dual catalysis, electron donor–acceptor (EDA) complexes, energy-transfer (EnT) catalysis, and direct photolysis. Collectively, these methods have translated a broad range of useful transformations to be amenable to on-DNA synthesis and unlocked access to many medicinally valuable motifs.  

  • DEL-Related Publications

    Chapter Two - Considerations, tactics, and best practices towards lead generation in drug discovery

    Darren V.S. Green a, Paul D. Leeson b, Robert J. Young Progress in Medicinal Chemistry   DOI: 10.1016/bs.pmch.2026.10.001 Abstract The Hit to Lead phase of current drug discovery practice has become a vital element in setting firm foundations for discovery programmes in the quest for new medicines, bridging the gap between screening hits and substantive investment in lead optimisation programmes. This is not intended to be a comprehensive review of the area, but rather a discussion around observations exploring the options and opportunities in contemporary and future practice. It is framed around the premises of comparing the extent of investment, chances of success, and quality of output – notably in the context of the influence of AI and other changing practices in drug discovery. Key examples are chosen to illustrate the diversity of leads pursued and the levels of investments required to deliver in some areas.

  • DEL-Related Publications

    Metal-free, photochemical on-DNA thiol–yne reaction for the stereoselective synthesis of -alkenyl sulfides and vinyl sulfoximines

    Fanming Zeng, Zhirong Zheng, Yagong Wang, Ivan Hu, Xue Zhao, Feng Fan, Lijun Xue, Kexin Yang, Yun Jin Hu Chemical Communications DOI: 10.1039/d6cc05768c Abstract We present visible-light-driven, metal-free on-DNA thiol–yne reaction using benzil under 365 nm light to synthesize alkenyl sulfides. This mild, aqueous method preserves DNA integrity and enables direct conversion to alkenyl sulfoximines, expanding the chemical space for DNA-encoded library screening.

  • DEL-Related Publications

    Tools for DNA-encoded library synthesis

    Johannes Bingold, Zhuo Li, Lisa Liang, Johannes Schmidt, Chun Zhang, Andreas Brunschweiger Chemical Communications DOI: 10.1039/d6cc05320c   Abstract DNA-encoded libraries (DELs) are a widely used technology for screening drug-like compounds en masse on biological targets. DEL screens help in assessing the ligandability of biological targets, yielding chemical biology probes, and identifying starting points for clinical drug development. DELs are most often synthesized by combinatorial chemistry routes in homogeneous aqueous solutions to obtain libraries with vast numbers of compounds. Aqueous conditions, the chemical reactivity of the DNA barcode, and the combinatorial workflow limit the synthesis methodology to a few validated DEL synthesis methods. In this review, we will discuss strategies to broaden the scope of reactions for DEL synthesis. These are barcoding strategies that include chemically modified DNA barcodes, solid-phase strategies, methods to solubilize the polar, polycationic DNA in non-aqueous organic solvents, and tailored catalysts for DNA-encoded chemistry.

  • DEL-Related Publications

    DNA Directed Chemistry: Scalable Programmed DNA-Encoded Library Synthesis for More Chemically Diverse and Drug-Like Libraries

    Spurti U Akki , Kirill Novikov , Divya Kanichar , Patrick J McEnaney , Tracy Chan , Vincent Lee , Jacob H Pachter , Joshua L Turnbull , Nikhil Jain , Virja A Pandya , Nathaniel H Stanley , Dong Min Mun , Christoph Klein , Boris P Belotserkovskii , R. Edward Watts ChemRxiv DOI: 10.26434/chemrxiv.15007812/v3 Abstract DNA-Encoded Libraries (DELs) are indispensable high-throughput platforms in drug discovery, but the widely adopted split-and-pool synthesis method is fundamentally limited: the DNA merely records, rather than directs, the steps of chemistry. This lack of programmatic control imposes mandatory downstream chemistry congruency, restricts structural diversity, and inevitably generates a combinatorial explosion of un-drug-like molecules, hindering both hit-finding and the acquisition of structurally informative data required for machine learning (ML) models. To resolve these core constraints, we developed Programmed DEL Synthesis (PDS), a robust, industrially applicable platform for non-combinatorial DEL construction in which the DNA actively directs the synthesis. PDS is built upon a sort-and-pool mechanism expanded by three key innovations: sequence-specific installation of first building blocks using charged carrier codons, a multinomial encoding strategy that enables libraries exceeding 20 billion unique encodings in three chemical steps, and non-combinatorial germline assembly that allows for the programmatic omission of undesirable building block combinations. We demonstrate the platform with Library i01, a three-step, threepathway library employing 137 trifunctional scaffolds. The design successfully programmed the systematic merging and un-merging of three mutually incompatible reaction pathways: Acid→Aldehyde→Amine, Amine→Aldehyde→Acid, and Aldehyde→Acid→Amine within a single synthesis. Pilot affinity selections against Carbonic Anhydrase (BCA-II) validated the high fidelity of DNA encoding and efficient building block installation across all steps and pathways, confirming the platform's robust utility for selection. PDS transforms chemical congruency and drug-likeness into programmable properties, offering a precise, efficient solution that improves library quality without sacrificing chemical space. Crucially, PDS enables the construction of structurally tailored 2nd Generation DELs needed to provide the high-resolution data required for productive ML-driven active learning cycles, establishing a critical operational link for modern drug development.

Product & Services

OpenDEL™ - Small Molecule

Starting Your Journey to Access the Vast Chemical Space

The Kit

  • 57 Libraries
  • ~3.8Bn compounds
  • 10 DEL samples

 

To Access

  • Fully Enumerated Molecules
  • Building Block Structures
  • DNA Codon Sequences
  • Scaffolds Information

 

✔ No Structure Disclosure Fee

✔ No Compound IP License Fee
Learn More more Quote more
case_01
OpenDEL™ - Small Molecule
01

OpenDEL™ Screening

OpenDEL™ screening is carried out by our team of experienced professionals, proficient in handling over 50 different target types including protein-protein interactions, kinases, enzymes, transcription factors, and RNA targets. Our team typically completes the screening experiments within 1-2 weeks. 
Learn More more Quote more
case_01
OpenDEL™ Screening
02

OpenDEL™ Sequencing

HitGen offers high-quality and gold sequencing service includes. 
  • Global Sample Shipment

  • Outstanding Sequencing Quality

  • Lightning-speed Result Delivery

  • Diverse Sequencing Options

Learn More more Quote more
case_01
OpenDEL™ Sequencing
03

OpenDEL™ Hit Proposal

Analyzing DEL selection data and choosing the right compounds for follow-up necessitates multidisciplinary expertise encompassing biology, computational science, and chemistry. This includes a deep understanding of the experimental design and mechanisms of action (MOAs) in biology, data processing and analysis in computational science, and aspects of both synthetic and DEL chemistry
Learn More more Quote more
case_01
OpenDEL™ Hit Proposal
04

OpenDEL™ Off-DNA Synthesis

HitGen Chemical Services: Innovation-Driven and Precision-Empowered.

We transform your DEL hits into tangible results by delivering the pure, complex structures critical for validating discoveries and accelerating their advancement.

Choose Your Path:

A. Traditional Chemical Synthesis @ HitGen 
B. High Throughput Chemical Synthesis @ HitGen

Learn More more Quote more
case_01
OpenDEL™ Off-DNA Synthesis
05

What are people in the community saying?

Connect with peers. Access breakthrough science. Spark your next discovery.

  • qAmghJ8oZ9
    qAmghJ8oZ9

    Oliver J. Corrigan, Sarah L. Allinson, Jamie H. Docherty

    RSC Medicinal Chemistry

    DOI:10.1039/d6md00764c

    Abstract

                      b4ff6980bbe98cf4778618ff249fe408.png

    DNA-encoded libraries (DELs) have become a mainstay of small-molecule discovery, enabling millions to billions of compounds to be screened in a single pooled affinity selection in which each small molecule is covalently linked to a unique DNA identifier. However, the chemistry available for their construction remains limited compared to conventional synthetic chemistry. On-DNA chemistry is constrained by the requirement for aqueous, dilute, and DNA-compatible conditions. Classical on-DNA reactions such as amide coupling, reductive amination, SNAr and transition-metal cross-coupling have enabled reliable library synthesis, but they tend to favour planar, sp2-rich products. Photochemistry and photocatalysis have recently emerged as a powerful strategy to broaden this toolbox. Excited-state activation opens reaction pathways that are difficult or impossible to reach through conventional ground-state chemistry and can facilitate novel transformations towards the construction of more complex and sp3-rich scaffolds. This review surveys the field of on-DNA photochemistry, looking at different activation modes including photoredox single-electron transfer (SET), hydrogen-atom transfer (HAT), metallaphotoredox dual catalysis, electron donor–acceptor (EDA) complexes, energy-transfer (EnT) catalysis, and direct photolysis. Collectively, these methods have translated a broad range of useful transformations to be amenable to on-DNA synthesis and unlocked access to many medicinally valuable motifs.

     

  • qAmghJ8oZ9
    qAmghJ8oZ9

    Ethan M. Hartman, Jeffrey D. Martell

    Chemical Science

    DOI: 10.1039/d6sc05041g

    Abstract

            A new approach for DEL synthesis that leverages DNA annealing to bring a catalyst in proximity to an on-DNA substrate. The utility of this method was demonstrated through aliphatic alcohol oxidation achieving high conversion under mild conditions.

    Compared to traditional methods for screening small molecule drug candidates, DNA-encoded libraries (DELs) offer greatly increased throughput by tethering each small molecule to unique DNA barcodes, allowing simultaneous screening of billions of small molecules in a single test-tube. Impressive advances have been made in adapting traditional organic reactions to be DNA-compatible, allowing for the synthesis of DELs with ever-expanding chemical diversity. Nonetheless, DNA is a fragile molecule that is damaged by many chemical reaction conditions, making these conditions incompatible with DEL synthesis. The fragility of DNA therefore necessitates the development of new platforms to accelerate the desired transformation of the tethered small molecules while minimizing damage to the DNA barcodes. Here, we report a DNA-scaffolded catalysis platform for high-yielding, high-selectivity transformations in the construction of DELs under mild conditions. Through DNA-scaffolding, the catalyst is brought in proximity to DNA-tethered small molecules, lowering the catalyst concentration needed and minimizing off-target DNA damage. We demonstrate the platform in the context of aliphatic alcohol oxidation, a transformation for which conventional reactions with free-floating catalysts cause oxidative DNA damage. We further demonstrate that the DNA-scaffolded DEL synthesis platform can be incorporated into existing DEL synthesis workflows. We anticipate that the DNA-scaffolded DEL synthesis platform will find broad utility in improving the DNA-compatibility of organic transformations and will expand the toolkit of DNA-compatible chemical reactions.

  • qAmghJ8oZ9
    qAmghJ8oZ9

    Darren V.S. Green a, Paul D. Leeson b, Robert J. Young

    Progress in Medicinal Chemistry

     

    DOI: 10.1016/bs.pmch.2026.10.001

    Abstract

    The Hit to Lead phase of current drug discovery practice has become a vital element in setting firm foundations for discovery programmes in the quest for new medicines, bridging the gap between screening hits and substantive investment in lead optimisation programmes.

    This is not intended to be a comprehensive review of the area, but rather a discussion around observations exploring the options and opportunities in contemporary and future practice. It is framed around the premises of comparing the extent of investment, chances of success, and quality of output – notably in the context of the influence of AI and other changing practices in drug discovery. Key examples are chosen to illustrate the diversity of leads pursued and the levels of investments required to deliver in some areas.

  • HitGen
    HitGen

    Johannes Bingold, Zhuo Li, Lisa Liang, Johannes Schmidt, Chun Zhang, Andreas Brunschweiger

    Chemical Communications

    DOI: 10.1039/d6cc05320c

     

    Abstract

    DNA-encoded library synthesis can draw on several tools for improving library quality and reaction development. These include tailored catalysts, solvent systems, solid phases, barcoding strategies and purification methods.

    DNA-encoded libraries (DELs) are a widely used technology for screening drug-like compounds en masse on biological targets. DEL screens help in assessing the ligandability of biological targets, yielding chemical biology probes, and identifying starting points for clinical drug development. DELs are most often synthesized by combinatorial chemistry routes in homogeneous aqueous solutions to obtain libraries with vast numbers of compounds. Aqueous conditions, the chemical reactivity of the DNA barcode, and the combinatorial workflow limit the synthesis methodology to a few validated DEL synthesis methods. In this review, we will discuss strategies to broaden the scope of reactions for DEL synthesis. These are barcoding strategies that include chemically modified DNA barcodes, solid-phase strategies, methods to solubilize the polar, polycationic DNA in non-aqueous organic solvents, and tailored catalysts for DNA-encoded chemistry.

  • HitGen
    HitGen

    Fanming Zeng, Zhirong Zheng, Yagong Wang, Ivan Hu, Xue Zhao, Feng Fan, Lijun Xue, Kexin Yang, Yun Jin Hu

    Chemical Communications

    DOI: 10.1039/d6cc05768c

    Abstract

    A metal-free, benzil-photocatalyzed on-DNA thiol–yne reaction enables the highly regio- and stereoselective synthesis of Z-alkenyl sulfides and downstream alkenyl sulfoximines for DEL applications.

    We present visible-light-driven, metal-free on-DNA thiol–yne reaction using benzil under 365 nm light to synthesize alkenyl sulfides. This mild, aqueous method preserves DNA integrity and enables direct conversion to alkenyl sulfoximines, expanding the chemical space for DNA-encoded library screening.

  • HitGen
    HitGen

    Spurti U Akki , Kirill Novikov , Divya Kanichar , Patrick J McEnaney , Tracy Chan , Vincent Lee , Jacob H Pachter , Joshua L Turnbull , Nikhil Jain , Virja A Pandya , Nathaniel H Stanley , Dong Min Mun , Christoph Klein , Boris P Belotserkovskii , R. Edward Watts

    ChemRxiv

    DOI: 10.26434/chemrxiv.15007812/v3

    Abstract

    DNA-Encoded Libraries (DELs) are indispensable high-throughput platforms in drug discovery, but the widely adopted split-and-pool synthesis method is fundamentally limited: the DNA merely records, rather than directs, the steps of chemistry. This lack of programmatic control imposes mandatory downstream chemistry congruency, restricts structural diversity, and inevitably generates a combinatorial explosion of un-drug-like molecules, hindering both hit-finding and the acquisition of structurally informative data required for machine learning (ML) models. To resolve these core constraints, we developed Programmed DEL Synthesis (PDS), a robust, industrially applicable platform for non-combinatorial DEL construction in which the DNA actively directs the synthesis. PDS is built upon a sort-and-pool mechanism expanded by three key innovations: sequence-specific installation of first building blocks using charged carrier codons, a multinomial encoding strategy that enables libraries exceeding 20 billion unique encodings in three chemical steps, and non-combinatorial germline assembly that allows for the programmatic omission of undesirable building block combinations. We demonstrate the platform with Library i01, a three-step, threepathway library employing 137 trifunctional scaffolds. The design successfully programmed the systematic merging and un-merging of three mutually incompatible reaction pathways: Acid→Aldehyde→Amine, Amine→Aldehyde→Acid, and Aldehyde→Acid→Amine within a single synthesis. Pilot affinity selections against Carbonic Anhydrase (BCA-II) validated the high fidelity of DNA encoding and efficient building block installation across all steps and pathways, confirming the platform's robust utility for selection. PDS transforms chemical congruency and drug-likeness into programmable properties, offering a precise, efficient solution that improves library quality without sacrificing chemical space. Crucially, PDS enables the construction of structurally tailored 2nd Generation DELs needed to provide the high-resolution data required for productive ML-driven active learning cycles, establishing a critical operational link for modern drug development.

Messages and Feedback

By submitting your information, you acknowledge having received, read and understood our Privacy Notice as made available above.

logo
logo